vs
C4 Therapeutics, Inc.（CCCC）与FIRST US BANCSHARES, INC.（FUSB）财务数据对比。点击上方公司名可切换其他公司
C4 Therapeutics, Inc.的季度营收约是FIRST US BANCSHARES, INC.的1.1倍（$11.0M vs $10.4M），FIRST US BANCSHARES, INC.净利率更高（20.4% vs -186.0%，领先206.4%），C4 Therapeutics, Inc.同比增速更快（112.8% vs 7.1%），过去两年C4 Therapeutics, Inc.的营收复合增速更高（90.4% vs 2.6%）
C4 Therapeutics是一家临床阶段生物制药企业，专注于开发靶向蛋白降解疗法，用于治疗癌症及其他存在重大未满足医疗需求的严重疾病。公司依托自有专利TORPEDO平台设计小分子降解剂清除致病蛋白，目前拥有多条肿瘤领域研发管线，并与头部制药企业达成战略合作。
第一美国银行控股公司是一家银行控股企业，核心子公司第一公民银行在美国23个州经营着超过500家网点，另一家子公司硅谷银行则在15个州设有39个办事处，是美国规模较大的银行机构之一，总部位于北卡罗来纳州罗利。
CCCC vs FUSB — 直观对比
营收规模更大
CCCC
是对方的1.1倍
$10.4M
营收增速更快
CCCC
高出105.7%
7.1%
净利率更高
FUSB
高出206.4%
-186.0%
两年增速更快
CCCC
近两年复合增速
2.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $11.0M | $10.4M |
| 净利润 | $-20.5M | $2.1M |
| 毛利率 | — | — |
| 营业利润率 | -210.1% | 28.1% |
| 净利率 | -186.0% | 20.4% |
| 营收同比 | 112.8% | 7.1% |
| 净利润同比 | 40.7% | 24.2% |
| 每股收益（稀释后） | $-0.09 | $0.36 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCCCFUSB
| Q4 25 | $11.0M | $10.4M | ||
| Q3 25 | $11.2M | $10.5M | ||
| Q2 25 | $6.5M | $10.3M | ||
| Q1 25 | $7.2M | $9.8M | ||
| Q4 24 | $5.2M | $9.7M | ||
| Q3 24 | $15.4M | $10.1M | ||
| Q2 24 | $12.0M | $10.0M | ||
| Q1 24 | $3.0M | $9.9M |
净利润CCCCFUSB
| Q4 25 | $-20.5M | $2.1M | ||
| Q3 25 | $-32.2M | $1.9M | ||
| Q2 25 | $-26.0M | $155.0K | ||
| Q1 25 | $-26.3M | $1.8M | ||
| Q4 24 | $-34.6M | $1.7M | ||
| Q3 24 | $-24.7M | $2.2M | ||
| Q2 24 | $-17.7M | $2.1M | ||
| Q1 24 | $-28.4M | $2.1M |
营业利润率CCCCFUSB
| Q4 25 | -210.1% | 28.1% | ||
| Q3 25 | -306.4% | 23.9% | ||
| Q2 25 | -441.0% | 1.6% | ||
| Q1 25 | -402.9% | 23.8% | ||
| Q4 24 | -728.4% | 23.8% | ||
| Q3 24 | -183.9% | 29.2% | ||
| Q2 24 | -178.6% | 27.4% | ||
| Q1 24 | -1060.2% | 27.8% |
净利率CCCCFUSB
| Q4 25 | -186.0% | 20.4% | ||
| Q3 25 | -286.4% | 18.4% | ||
| Q2 25 | -402.6% | 1.5% | ||
| Q1 25 | -363.7% | 18.1% | ||
| Q4 24 | -667.8% | 17.6% | ||
| Q3 24 | -160.6% | 22.0% | ||
| Q2 24 | -147.6% | 21.2% | ||
| Q1 24 | -933.2% | 21.3% |
每股收益（稀释后）CCCCFUSB
| Q4 25 | $-0.09 | $0.36 | ||
| Q3 25 | $-0.44 | $0.32 | ||
| Q2 25 | $-0.37 | $0.03 | ||
| Q1 25 | $-0.37 | $0.29 | ||
| Q4 24 | $-0.50 | $0.29 | ||
| Q3 24 | $-0.35 | $0.36 | ||
| Q2 24 | $-0.26 | $0.34 | ||
| Q1 24 | $-0.41 | $0.34 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $74.6M | $73.5M |
| 总债务越低越好 | — | $10.9M |
| 股东权益账面价值 | $256.6M | $105.6M |
| 总资产 | $359.1M | $1.2B |
| 负债/权益比越低杠杆越低 | — | 0.10× |
8季度趋势，按日历期对齐
现金及短期投资CCCCFUSB
| Q4 25 | $74.6M | $73.5M | ||
| Q3 25 | $58.8M | $54.7M | ||
| Q2 25 | $78.2M | $54.0M | ||
| Q1 25 | $51.3M | $56.0M | ||
| Q4 24 | $55.5M | $47.2M | ||
| Q3 24 | $59.6M | $82.3M | ||
| Q2 24 | $73.1M | $58.2M | ||
| Q1 24 | $89.7M | $60.2M |
总债务CCCCFUSB
| Q4 25 | — | $10.9M | ||
| Q3 25 | — | $10.9M | ||
| Q2 25 | — | $10.9M | ||
| Q1 25 | — | $10.9M | ||
| Q4 24 | — | $10.9M | ||
| Q3 24 | — | $10.9M | ||
| Q2 24 | — | $10.8M | ||
| Q1 24 | — | $10.8M |
股东权益CCCCFUSB
| Q4 25 | $256.6M | $105.6M | ||
| Q3 25 | $154.4M | $104.2M | ||
| Q2 25 | $174.1M | $101.9M | ||
| Q1 25 | $195.1M | $101.2M | ||
| Q4 24 | $216.0M | $98.6M | ||
| Q3 24 | $242.7M | $98.5M | ||
| Q2 24 | $247.1M | $93.8M | ||
| Q1 24 | $258.3M | $92.3M |
总资产CCCCFUSB
| Q4 25 | $359.1M | $1.2B | ||
| Q3 25 | $265.5M | $1.1B | ||
| Q2 25 | $296.5M | $1.1B | ||
| Q1 25 | $319.5M | $1.1B | ||
| Q4 24 | $349.6M | $1.1B | ||
| Q3 24 | $376.1M | $1.1B | ||
| Q2 24 | $381.1M | $1.1B | ||
| Q1 24 | $398.4M | $1.1B |
负债/权益比CCCCFUSB
| Q4 25 | — | 0.10× | ||
| Q3 25 | — | 0.10× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | 0.11× | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | — | 0.12× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.1M | $12.3M |
| 自由现金流经营现金流 - 资本支出 | — | $9.1M |
| 自由现金流率自由现金流/营收 | — | 87.2% |
| 资本支出强度资本支出/营收 | — | 31.1% |
| 现金转化率经营现金流/净利润 | — | 5.79× |
| 过去12个月自由现金流最近4个季度 | — | $16.0M |
8季度趋势，按日历期对齐
经营现金流CCCCFUSB
| Q4 25 | $-22.1M | $12.3M | ||
| Q3 25 | $-31.2M | $4.2M | ||
| Q2 25 | $-12.1M | $3.9M | ||
| Q1 25 | $-33.3M | $1.8M | ||
| Q4 24 | $-17.9M | $7.8M | ||
| Q3 24 | $-24.1M | $1.9M | ||
| Q2 24 | $-5.0M | $2.5M | ||
| Q1 24 | $-18.1M | $825.0K |
自由现金流CCCCFUSB
| Q4 25 | — | $9.1M | ||
| Q3 25 | $-31.6M | $3.6M | ||
| Q2 25 | — | $1.6M | ||
| Q1 25 | — | $1.7M | ||
| Q4 24 | $-17.9M | $5.7M | ||
| Q3 24 | $-24.1M | $1.3M | ||
| Q2 24 | $-5.2M | $2.3M | ||
| Q1 24 | — | $-142.0K |
自由现金流率CCCCFUSB
| Q4 25 | — | 87.2% | ||
| Q3 25 | -281.5% | 34.2% | ||
| Q2 25 | — | 16.0% | ||
| Q1 25 | — | 17.2% | ||
| Q4 24 | -346.5% | 58.2% | ||
| Q3 24 | -157.2% | 12.7% | ||
| Q2 24 | -43.1% | 23.5% | ||
| Q1 24 | — | -1.4% |
资本支出强度CCCCFUSB
| Q4 25 | — | 31.1% | ||
| Q3 25 | 3.7% | 5.9% | ||
| Q2 25 | — | 21.8% | ||
| Q1 25 | — | 0.7% | ||
| Q4 24 | 0.1% | 21.6% | ||
| Q3 24 | 0.1% | 6.6% | ||
| Q2 24 | 1.6% | 2.0% | ||
| Q1 24 | 0.0% | 9.8% |
现金转化率CCCCFUSB
| Q4 25 | — | 5.79× | ||
| Q3 25 | — | 2.18× | ||
| Q2 25 | — | 25.16× | ||
| Q1 25 | — | 0.99× | ||
| Q4 24 | — | 4.53× | ||
| Q3 24 | — | 0.87× | ||
| Q2 24 | — | 1.20× | ||
| Q1 24 | — | 0.39× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
